1,359
Views
106
CrossRef citations to date
0
Altmetric
Research Article

Mechanisms and clinical implications of renal drug excretion*

&
Pages 299-351 | Published online: 04 Mar 2002

REFERENCES

  • Marshall E.K., Vickers J.L. The Mechanism of the Elimination of Phenolsulphonphtalein by the Kidney—A Proof of Secretion by the Convoluted Tubules. Bull. Johns Hopkins Hosp. 1923; 34: 1–6
  • Rennick B.R., Moe G.K., Lyons R.H., Hoobler S.W., Neligh R. Absorption and Renal Excretion of the Tetraethylammonium Ion. J. Pharmacol. Exp. Ther. 1947; 91: 210–217
  • Dekant W., Vamvakas S. Biotransformation and Membrane Transport in Nephrotoxicity. Crit. Rev. Toxicol. 1996; 26: 309–334
  • Inui K.I., Masuda S., Saito H. Cellular and Molecular Aspects of Drug Transport in the Kidney. Kidney Int. 2000; 58: 944–958
  • Koepsell H., Gorboulev V., Arndt P. Molecular Pharmacology of Organic Cation Transporters in Kidney. J. Membr. Biol. 1999; 167: 103–117
  • Sweet D.H., Pritchard J.B. The Molecular Biology of Renal Organic Anion and Organic Cation Transporters. Cell Biochem. Biophys. 1999; 31: 89–118
  • Van Aubel R.A.M.H., Masereeuw R., Russel F.G.M. Molecular Pharmacology of Renal Organic Anion Transporters. Am. J. Physiol Renal Physiol 2000; 279: F216–F232
  • Smith H.W., Goldring W., Chasis H. The Measurement of the Tubular Excretory Mass, Effective Blood Flow and Filtration Rate in the Normal Kidney. J. Clin. Invest. 1938; 17: 263–278
  • Smith H.W. The Kidney: Structure and Function in Health and Disease. Oxford University Press, New York 1951
  • Berndt W.O. Toxicology of the Kidney, J.B. Hook. Raven Press, New York 1981; 1–29
  • Brater D.C., Sokol P.P., Hall S.D., McKinney T.D. Renal Elimination of Drugs: Methods and Determinants. The Kidney: Physiology and Pathophysiology, D.W. Seldin, G. Giebisch. Raven Press, New York 1992; 3597
  • Foulkes E.C. Functional Assessment of the Kidney. Toxicology of the Kidney, J.B. Hook, R.S. Goldstein. Raven Press. 1993; 37–60
  • van Ginneken C.A.M., Russel F.G.M. Saturable Pharmacokinetics in the Renal Excretion of Drugs. Clin. Pharmacokin. 1989; 16: 38–54
  • Möller J.V., Sheikh M.I. Renal Organic Anion Transport System: Pharmacological, Physiological, and Biochemical Aspects. Pharmacol. Rev. 1983; 34: 315–358
  • Pritchard J.B., Miller D.S. Mechanisms Mediating Renal Secretion of Organic Anions and Cations. Physiol. Rev. 1993; 73: 765–769
  • Roch-Ramel F. Renal Transport of Organic Anions. Curr. Opin. Nephrol. Hypertens. 1998; 7: 517–524
  • Ullrich K.J. Specificity of Transporters for ‘Organic Anions’ and ‘Organic Cations’ in the Kidney. Biochim. Biophys. Acta 1994; 1197: 45–62
  • Ullrich K.J. Renal Transporters for Organic Anions and Organic Cations. Structural Requirements for Substrates. J. Membr. Biol. 1997; 158: 95–107
  • Chasis H., Redish J., Goldring W., Ranges H.A., Smith H.W. The Use of Sodium p-Aminohippurate for the Functional Evaluation of the Human Kidney. J. Clin. Invest. 1945; 24: 583–588
  • Pitts R.F. Tubular Secretion, R.F. Pitts. Year Book Med. Publ., Chicago 1974; 140–157
  • Maunsbach A.B. Observations on the Segmentation of the Proximal Tubule in the Rat Kidney. Comparison of Results from Phase Contrast Fluorescence and Electron Microscopy. J. Ultrastruct. Res. 1966; 16: 239–258
  • McKinney T.D. Heterogeneity of Organic Base Secretion by Proximal Tubules. Am. J. Physiol. 1982; 243: F404–F407
  • Schäli C., Roch-Ramel F. Transport and Metabolism of [3H]Morphine in Isolated Nonperfused Proximal Tubule Segments of the Rabbit Kidney. J. Pharmacol. Exp. Ther. 1982; 223: 811–815
  • Schäli C., Schild L., Overney J., Roch-Ramel F. Secretion of Tetraethylammonium by Proximal Tubules of Rabbit Kidneys. Am. J. Physiol. 1983; 245: F238–F246
  • Shimomura A., Chonko A.M., Grantham J.J. Basis for Heterogeneity of para-Aminohippurate Secretion in Rabbit Proximal Tubules. Am. J. Physiol. 1981; 240: F430–F436
  • Woodhall P.B., Tisher C.C., Simonton C.A., Robinson R.K. Relationship Between para-Aminohippurate Secretion and Cellular Morphology in Rabbit Proximal Tubules. J. Clin. Invest. 1978; 61: 1320–1329
  • Schäli C., Roch-Ramel F. Uptake of [3H]PAH and [14C]Urate into Isolated Proximal Segments of the Pig Kidney. Am. J. Physiol. 1981; 241: F591–F596
  • Schuster V.L. Organic Anion Transporters. Molecular Nephrology, Kidney Function in Health and Disease, D. Schlöndorff, J.V. Bonventre. Marcel Dekker, New York 1995; 309–318
  • Hall S., Rowland M. Influence of Fraction Unbound upon the Renal Clearance of Furosemide in the Isolated Perfused Rat Kidney. J. Pharmacol. Exp. Ther. 1985; 232: 263–268
  • Levy G. Effect of Plasma Protein Binding on Renal Clearance of Drugs. J. Pharm. Sci. 1980; 69: 482–483
  • Besseghir K., Mosig D., Roch-Ramel F. Facilitation by Serum Albumin of Renal Tubular Secretion of Organic Anions. Am. J. Physiol. 1989; 256: F475–F484
  • Taft D.R., Sweeney K.R. The Influence of Protein Binding on the Elimination of Acetazolamide by the Isolated Perfused Rat Kidney: Evidence of Albumin-Mediated Tubular Secretion. J. Pharmacol. Exp. Ther. 1995; 274: 752–760
  • Berry C.A., Rector F.C., Jr. Renal Transport of Glucose, Amino Acids, Sodium, Chloride, and Water. The Kidney, B.M. Brenner, F.C. Rector, Jr. W.B. Saunders Company, Philadelphia 1991; 245–282
  • Hediger M.A., Kanai Y., You G., Nussberger S. Mammalian Ion-Coupled Solute Transporters. J. Physiol. 1995; 482: 7S–17S
  • Thorens B. Facilitated Glucose Transporters in Epithelial Cells. Annu. Rev. Physiol. 1993; 55: 591–608
  • Hoffman B.B., Ziyadeh F.N. Facilitative Glucose Transport Proteins and Sodium-Glucose Co-Transporters in the Kidney. Curr. Opin. Nephrol. Hypertens. 1995; 4: 406–411
  • Higgins J.T., Mulrow P.J., Jr. . Fluid and Electrolyte Disorders of Endocrine Diseases. Clinical Disorders of Fluid and Electrolyte Metabolism, M.H. Maxwell, C.R. Kleeman. McGraw-Hill, New York 1980
  • Moriwaki Y., Yamamoto T., Takahashi S., Hada T., Higashino K. Analysis of Uric Acid Transport in Renal Tubules Using Benzbromarone and Pyrazinamide. Int. J. Clin. Pharmacol. Ther. Toxicol. 1990; 28: 84–88
  • Maesaka J.K., Fishbane S. Regulation of Renal Urate Excretion: A Critical Review. Am. J. Kidney Dis. 1998; 32: 917–933
  • Rappa G., Finch R.A., Sartorelli A.C., Lorico A. New Insights into the Biology and Pharmacology of the Multidrug Resistance Protein (MRP) from Gene Knockout Models. Biochem. Pharmacol. 1999; 58: 557–562
  • Roch-Ramel F., Weiner I.M. Renal Excretion of Urate: Factors Determining the Actions of Drugs. Kidney Int. 1980; 18: 665–676
  • Christensen E.I., Nielsen S. Structural and Functional Features of Protein Handling in the Kidney Proximal Tubule. Semin. Nephrol. 1991; 11: 414–439
  • Cortney M.A., Sawin L.L., Weiss D.D. Renal Tubular Protein Absorption in the Rat. J. Clin. Invest. 1970; 49: 1–4
  • Kaloyanides G.J. Drug–Phospholipid Interactions: Role in Aminoglycoside Nephrotoxicity. Ren. Fail. 1992; 14: 351–357
  • Masereeuw R., Moons M.M., Smits P., Russel F.G.M. Glomerular Filtration and Saturable Absorption of Iohexol in the Isolated Perfused Rat Kidney. Br. J. Pharmacol. 1996; 119: 57–64
  • Goldberg J.P., Anderson R.J. Renal Metabolism and Excretion of Drugs. The Kidney: Physiology and Pathophysiology, D.W. Seldin, G. Giebisch. Raven Press, New York 1985; 2097–2110
  • Lock E.A., Reed C.J. Xenobiotic Metabolizing Enzymes of the Kidney. Toxicol. Pathol. 1998; 26: 18–25
  • Lohr J.W., Willsky G.R., Acara M.A. Renal Drug Metabolism. Pharmacol. Rev. 1998; 50: 107–141
  • Monks T.J., Lau S.S. Commentary: Renal Transport Processes and Glutathione Conjugated-Mediated Nephrotoxicity. Drug Metab. Dispos. 1987; 15: 437–441
  • Commandeur J.N.M., Stijntjes G.J., Vermeulen N.P.E. Enzymes and Transport Systems Involved in the Formation and Disposition of Glutathione S-Conjugates. Physiol. Rev. 1995; 47: 271–330
  • Hume R., Coughtrie M.W., Burchell B. Differential Localisation of UDP-Glucuronosyltransferase in Kidney During Human Embryonic and Fetal Development. Arch. Toxicol. 1995; 69: 242–247
  • Yokota H., Inoue H., Taniyama H., Kobayashi T., Iwano H., Kagawa Y., Okada H., Yuasa A. High Induction of Phenol UDP-Glucuronosyltransferase in the Kidney Medulla of Beta-Naphtoflavone-Treated Rats. Biochim. Biophys. Acta 1997; 1336: 165–170
  • Hughey R.P., Rankin B.B., Elce J.S., Curthoys N.P. Specificity of a Particulate Rat Renal Peptidase and its Localization Along with Other Enzymes of Mercapturic Acid Synthesis. Arch. Biochem. Biophys. 1978; 186: 211–217
  • Kluwe W.M., Hook J.B. Metabolic Activation of Nephrotoxic Haloalkanes. Fed. Proc. 1980; 39: 3129–3133
  • Newton J.F., Pasino D.A., Hook J.B. Acetaminophen Nephrotoxicity in the Rat: Quantitation of Renal Metabolic Activation In Vivo. Toxicol. Appl. Pharmacol. 1985; 78: 39–46
  • Daley-Yates P.T., McBrien D.C.H. Cisplatin Metabolites: A Method for their Separation and for Measurement of their Renal Clearances In Vivo. Biochem. Pharmacol. 1984; 33: 3063–3070
  • Sheikh-Hamad D., Timmins K., Jalali Z. Cisplatin-Induced Renal Toxicity: Possible Reversal by N-Acetylcysteine Treatment. J. Am. Soc. Nephrol. 1997; 8: 1640–1645
  • Bennett W.M. Insights into Chronic Cyclosporine Nephrotoxicity. Int. J. Clin. Pharmacol. Ther. 1996; 34: 515–519
  • Delacruz L., Bach P.H. The Role of Ochratoxin A Metabolism and Biochemistry in Animal and Human Nephrotoxicity. J. Biopharm. Sci. 1990; 1: 277–304
  • Gekle M., Silbernagl S. The Role of the Proximal Tubule in Ochrotoxin A Nephrotoxicity In Vivo: Toxodynamic and Toxokinetic Aspects. Renal Physiol. Biochem. 1994; 17: 40–49
  • Russel F.G.M., Wouterse A.C., van Ginneken C.A.M. Physiologically Based Kidney Model for the Renal Clearance of Phenolsulfonphthalein and the Interaction with Probenecid and Salicyluric Acid in the Dog. J. Pharmacokin. Biopharm. 1987; 15: 349–368
  • Russel F.G.M., Wouterse A.C., van Ginneken C.A.M. Physiologically based Kidney Model for the Renal Clearance of Salicyluric Acid and the Interaction with Phenolsulfonphthalein in the Dog. Drug Metab. Dispos. 1987; 15: 695–701
  • Russel F.G.M., Wouterse A.C., van Ginneken C.A.M. Physiologically based Kidney Model for the Renal Clearance of Iodopyracet and the Interaction with Probenecid in the Dog. Biopharm. Drug Dispos. 1989; 10: 137–152
  • Cox P.G.F., Moons M.M., Russel F.G.M., van Ginneken C.A.M. Renal Handling of Salicyluric Acid in the Isolated Perfused Rat Kidney: Evidence for Accumulation in Tubular Cells. J. Pharmacol. Exp. Ther. 1989; 251: 750–755
  • Boom S.P.A., Moons M.M., Russel F.G.M. Renal Tubular Transport of Cimetidine in the Isolated Perfused Kidney of the Rat. Drug Metab. Dispos. 1994; 22: 148–153
  • Masereeuw R., Moons M.M., Russel F.G.M. Renal Excretion and Accumulation Kinetics of 2-Methylbenzoylgycine in the Isolated Perfused Rat Kidney. J. Pharm. Pharmacol. 1996; 48: 560–565
  • Masereeuw R., Moons M.M., Russel F.G.M. Disposition of 4-Methylbenzoylglycine in Rat Isolated Perfused Kidney and Effects of Hippurates on Renal Mitochondrial Metabolism. J. Pharm. Pharmacol. 1998; 50: 1397–1404
  • He Y.-L., Tanigawara Y., Kamiya A., Hori R. Moment Analysis of Drug Disposition in Kidney. VI: Assessment of In Vivo Transmembrane Transport of p-Aminohippurate in Tubular Epithelium. J. Pharmacokin. Biopharm. 1991; 19: 667–690
  • Kamiya A., Tanigawara Y., Saito Y., Hayashi Y., Aiba T., Inui K., Hori R. Moment Analysis of Drug Disposition in Kidney. II: Urine pH-Dependent Tubular Secretion of Tetraethylammonium in the Isolated Perfused Rat Kidney. J. Pharm. Sci. 1990; 79: 692–697
  • Boom S.P.A., Gribnau F.W.J., Russel F.G.M. Organic Cation Transport and Cationic Drug Interactions in Freshly Isolated Proximal Tubular Cells of the Rat. J. Pharmacol. Exp. Ther. 1992; 263: 445–450
  • Boom S.P.A., Russel F.G.M. Cimetidine Uptake and Interactions with Cationic Drugs in Freshly Isolated Proximal Tubular Cells of the Rat. J. Pharmacol. Exp. Ther. 1993; 267: 1039–1044
  • Cox P.G.F., van Os C.H., Russel F.G.M. Accumulation of Salicylic Acid and Indomethacin in Isolated Proximal Tubular Cells of the Rat Kidney. Pharmacol. Res. 1993; 27: 241–252
  • Masereeuw R., van den Bergh E.J., Bindels R.J.M., Russel F.G.M. Characterization of Fluorescein Transport in Isolated Proximal Tubular Cells of the Rat: Evidence for Mitochondrial Accumulation. J. Pharmacol. Exp. Ther. 1994; 269: 1261–1267
  • Miller J.H. Sodium-Sensitive, Probenecid-Insensitive p-Aminohippuric Acid Uptake in Cultured Renal Proximal Tubule Cells of the Rabbit. Proc. Soc. Exp. Biol. Med. 1992; 199: 298–304
  • Berner W., Kinne R. Transport of p-Aminohippuric Acid by Plasma Membrane Vesicles Isolated from Rat Kidney Cortex. Pflügers Arch. 1976; 361: 269–277
  • Kinsella J.L., Holohan P.D., Pessah N.I., Ross C.R. Transport of Organic Ions in Renal Cortical Luminal and Antiluminal Membrane Vesicles. J. Pharmacol. Exp. Ther. 1979; 209: 443–450
  • Kinsella J.L., Holohan P.D., Pessah N.I., Ross C.R. Isolation of Luminal and Antiluminal Membranes from Dog Kidney Cortex. Biochim. Biophys. Acta 1979; 552: 468–477
  • Haase W., Schafer A., Murer H., Kinne R. Studies on the Orientation of Brush-Border Membrane Vesicles. Biochem. J. 1978; 172: 57–62
  • Busch A.E., Waldegger S., Murer H., Lang F. The Molecules of Proximal Tubular Transport: Insights From Electrophysiology. Nephron 1996; 72: 1–8
  • Gründemann D., Gorboulev V., Gambaryan S., Veyhl M., Koepsell H. Drug Excretion Mediated by a New Prototype of Polyspecific Transporter. Nature 1994; 372: 549–552
  • Kwon O., Kwon H.M., Hong S.K., Goldinger J.M. Size Selected mRNA Induces Expression of p-Aminohippurate Transport in Xenopus Oocytes. Proc. Soc. Exp. Biol. Med. 1989; 192: 205–208
  • Wolff N.A., Philpot R.M., Miller D.S., Pritchard J.B. Functional Expression of Renal Organic Anion Transport in Xenopus laevis Oocytes. Mol. Cell. Biochem. 1992; 114: 35–41
  • Fujita K., Fujita H.M. Reversibility of Antibiotic Incorporation in Large Organelles of Kidney Cell. Int. J. Clin. Pharmacol. Ther. Toxicol. 1985; 23: 291–294
  • Fujita K., Fujita H.M. The Localization of Antibiotics by Continuous Sucrose Gradient Density. Int. J. Clin. Pharmacol. Ther. Toxicol. 1985; 23: 288–290
  • van Aubel R.A.M.H., van Kuijck M.A., Koenderink J.B., Deen P.M.T., van Os C.H., Russel F.G.M. Adenosine Triphosphate-Dependent Transport of Anionic Conjugates by the Rabbit Multidrug Resistance-Associated Protein Mrp2 Expressed in Insect Cells. Mol. Pharmacol. 1998; 53: 1062–1067
  • Evers R., Kool M., van Deemter L., Janssen H., Calafat J., Oomen L.C., Paulusma C.C., Oude Elferink R.P.J., Baas F., Schinkel A.H., Borst P. Drug Export Activity of the Human Canalicular Multispecific Organic Anion Transporter in Polarized Kidney MDCK Cells Expressing cMOAT (MRP) cDNA. J. Clin. Invest. 1998; 101: 1310–1319
  • Mehrens T., Lelleck S., Cetinkaya I., Knollmann M., Hohage H., Gorboulev V., Boknik P., Koepsell H., Schlatter E. The Affinity of the Organic Cation Transporter rOCT1 is Increased by Protein Kinase C-Dependent Phosphorylation. J. Am. Soc. Nephrol. 2000; 11: 1216–1224
  • Sweet D.H., Miller D.S., Pritchard J.B. Localization of an Organic Anion Transporter–GFP Fusion Construct (rROAT1–GFP) in Intact Proximal Tubules. Am. J. Physiol. 1999; 276: F864–F873
  • Masereeuw R., Saleming W.C., Miller D.S., Russel F.G.M. Interaction of Fluorescein with the Dicarboxylate Carrier in Rat Kidney Cortex Mitochondria. J. Pharmacol. Exp. Ther. 1996; 279: 1559–1565
  • Masereeuw R., Russel F.G.M., Miller D.S. Multiple Pathways of Organic Anion Secretion in Renal Proximal Tubule Revealed by Confocal Microscopy. Am. J. Physiol. 1996; 271: F1173–F1182
  • Miller D.S., Barnes D.M., Pritchard J.B. Confocal Microscopic Analysis of Fluorescein Compartmentation Within Crab Urinary Bladder Cells. Am. J. Physiol. 1994; 267: R695–R704
  • Miller D.S., Pritchard J.B. Nocodazole Inhibition of Organic Anion Secretion in Teleost Renal Proximal Tubules. Am. J. Physiol. 1994; 267: R695–R704
  • Miller D.S., Letcher S., Barnes D.M. Fluorescence Imaging Study of Organic Anion Transport from Renal Proximal Tubule Cell to Lumen. Am. J. Physiol. 1996; 271: F508–F520
  • Pietruck F., Ullrich K.J. Transport Interactions of Different Organic Cations During Their Excretion by the Intact Kidney. Kidney Int. 1995; 47: 1647–1657
  • Ullrich K.J., Rumrich G., David C., Fritschz G. Bisubstrates: Substances That Interact with Both, Renal Contraluminal Organic Anion and Organic Cation Transport Systems. I. Amines, Piperidines, Piperazines, Azepines, Pyridines, Quinolines, Imidazoles, Guanidines, and Hydrazines. Pflügers Arch. 1993; 425: 280–299
  • Pritchard J.B. Luminal and Peritubular Steps in Renal Transport of p-Aminohippurate. Biochim. Biophys. Acta 1987; 906: 295–308
  • Shimada H., Moewes B., Burckhardt G. Indirect Coupling to Na of p-Aminohippuric Acid Uptake into Rat Renal Basolateral Membrane Vesicles. Am. J. Physiol. 1987; 253: F795–F801
  • Sekine T., Cha S.H., Endou H. The Multispecific Organic Anion Transporter (OAT) Family. Pflugers Arch. 2000; 440: 337–350
  • Burckhardt G., Wolff N.A. Structure of Renal Organic Anion and Cation Transporters. Am. J. Physiol. Renal Physiol. 2000; 278: F853–F866
  • Beyer K.H., Russo H.F., Tillson E.K., Miller A.K., Verwey W.F., Gass S.R. ‘Benemid’ p-(Di-n-Propylsulfamyl)-Benzoic Acid: Its Renal Affinity and Its Elimination. Am. J. Physiol. 1951; 166: 625–640
  • Uwai Y., Okuda M., Takami K., Hashimoto Y., Inui K. Functional Characterization of the Rat Multispecific Organic Anion Transporter OAT1 Mediating Basolateral Uptake of Anionic Drugs in the Kidney. FEBS Lett. 1998; 438: 321–324
  • Berndt W.O. Probenecid Binding by Renal Cortical Slices and Homogenates. Proc. Soc. Exp. Biol. Med. 1967; 126: 123–126
  • Weiner I.M., Washington J.A.I., Mudge G.H. On the Mechanism of Action of Probenecid on Renal Tubular Secretion. Bull. Johns Hopkins Hosp. 1960; 106: 333–346
  • Sheikh M.I., Stahl M. Characteristics of Accumulation of Probenecid by Rabbit Cortical Slices. Am. J. Physiol. 1977; 232: F513–F523
  • Sekine T., Watanabe N., Hosoyamada M., Kanai Y., Endou H. Expression Cloning and Characterization of a Novel Multispecific Organic Anion Transporter. J. Biol. Chem. 1997; 272: 18526–18529
  • Sweet D.H., Wolff N.A., Pritchard J.B. Expression Cloning and characterization of ROAT1. The Basolateral Organic Anion Transporter in Rat Kidney. J. Biol. Chem. 1997; 272: 30088–30095
  • Chen X., Tsukaguchi H., Chen X.Z., Berger U.V., Hediger M.A. Molecular and Functional Analysis of SDCT2, a Novel Rat Sodium-Dependent Dicarboxylate Transporter. J. Clin. Invest. 1999; 103: 1159–1168
  • Kekuda R., Wang H., Huang W., Pajor A.M., Leibach F.H., Devoe L.D., Prasad P.D., Ganapathy V. Primary Structure and Functional Characteristics of a Mammalian Sodium-Coupled High Affinity Dicarboxylate Transporter. J. Biol. Chem. 1999; 274: 3422–3429
  • Chatsudthipong V., Dantzler W.H. PAH/a-KG Countertransport Stimulates PAH Uptake and Net Secretion in Isolated Rabbit Renal Tubules. Am. J. Physiol. 1992; 2631: F384–F391
  • Pritchard J.B. Intracellular a-Ketoglutarate Controls the Efficacy of Renal Organic Anion Transport. J. Pharmacol. Exp. Ther. 1995; 274: 1278–1284
  • Welborn J.R., Shpun S., Dantzler W.H., Wright S.H. Effect of a-Ketoglutarate on Organic Anion Transport in Single Rabbit Renal Proximal Tubules. Am. J. Physiol. 1998; 274: F165–F174
  • Siess E.A., Brocks D.G., Wieland O. Subcellular Distribution of Key Metabolites in Isolated Liver Cells from Fasted Rats. FEBS Lett. 1976; 69: 265–271
  • Soboll S., Scholz R., Friesl M., Elbers R., Heldt H.W. Distribution of Metabolites Between Mitochondria and Cytosol of Perfused Liver. Use of Isolated Liver Cells and Kidney Tubules in Metabolic Studies, J.M. Tager, H.D. Söling, J.R. Williamson. North-Holland Publishing Company, Amsterdam 1975; 29–40
  • Lu R., Chan B.S., Schuster V.L. Cloning of the Human Kidney PAH Transporter: Narrow Substrate Specificity and Regulation by Protein Kinase C. Am. J. Physiol. 1999; 276: F295–F303
  • Gekle M., Mildenberger S., Sauvant C., Bednarczyk D., Wright S.H., Dantzler W.H. Inhibition of Initial Transport Rate of Basolateral Organic Anion Carrier in Renal PT by BK and Phenylephrine. Am. J. Physiol 1999; 277: F251–F256
  • Halpin P.A., Renfro J.L. Renal Organic Anion Secretion: Evidence for Dopminergic and Adrenergic Regulation. Am. J. Physiol. 1996; 271: R1372–R1379
  • Takano M., Nagai J., Yasuhara M., Inui K. Regulation of p-Aminohippurate Transport by Protein Kinase C in OK Kidney Eptithelial Cells. Am. J. Physiol. 1996; 40: F469–F475
  • Kusuhara H., Sekine T., Utsunomiya-Tate N., Tsuda M., Kojima R., Cha S.H., Sugiyama Y., Kanai Y., Endou H. Molecular Cloning and Characterization of a New Multispecific Organic Anion Transporter from Rat Brain. J. Biol. Chem. 1999; 274: 13675–13680
  • Race J.E., Grassl S.M., Williams W.J., Holtzman E.J. Molecular Cloning and Characterization of Two Novel Human Renal Organic Anion Transporters (hOAT1 and hOAT3). Biochem. Biophys. Res. Commun. 1999; 255: 508–514
  • Takeda M., Sekine T., Endou H. Regulation by Protein Kinase C of Organic Anion Transport Driven by Rat Organic Anion Transporter 3 (rOAT3). Life Sci. 2000; 67: 1087–1093
  • Karniski L.P., Lotscher M., Fucentese M., Hilfiker H., Biber J., Murer H. Immunolocalization of Sat-1 Sulfate/Oxalate/Bicarbonate Anion Exchanger in the Rat Kidney. Am. J. Physiol. 1998; 275: F79–F87
  • Scheffer G.L., Kool M., Heijn M., de Haas M., Pijnenborg A.C., Wijnholds J., van Helvoort A., de Jong M.C., Hooijberg J.H., Mol C.A., van der Linden M., de Vree J.M., van der Valk P., Elferink R.P., Borst P., Scheper R.J. Specific Detection of Multidrug Resistance Proteins MRP1, MRP2, MRP3, MRP5, and MDR3 P-Glycoprotein with a Panel of Monoclonal Antibodies. Cancer Res. 2000; 60: 5269–5277
  • Wijnholds J., Mol C.A., van Deemter L., de Haas M., Scheffer G.L., Baas F., Beijnen J.H., Scheper R.J., Hatse S., De Clercq E., Balzarini J., Borst P. Multidrug-Resistance Protein 5 Is a Multispecific Organic Anion Transporter Able to Transport Nucleotide Analogs. Proc. Natl. Acad. Sci. USA 2000; 97: 7476–7481
  • Borst P., Evers R., Kool M., Wijnholds J. A Family of Drug Transporters: the Multidrug Resistance-Associated Proteins. J. Natl. Cancer Inst. 2000; 92: 1295–1302
  • Kool M., van der L.M., de Haas M., Scheffer G.L., de Vree J.M., Smith A.J., Jansen G., Peters G.J., Ponne N., Scheper R.J., Elferink R.P., Baas F., Borst P. MRP3, An Organic Anion Transporter Able to Transport Anti-Cancer Drugs. Proc. Natl. Acad. Sci. USA 1999; 96: 6914–6919
  • Kool M., van der L.M., de Haas M., Baas F., Borst P. Expression of Human MRP6, a Homologue of the Multidrug Resistance Protein Gene MRP1, in Tissues and Cancer Cells. Cancer Res. 1999; 59: 175–182
  • Tune B.M., Burg M.B., Patlak C.S. Charateristics of p-Aminohippurate Transport in Proximal Renal Tubules. Am. J. Physiol. 1969; 217: 1057–1063
  • Ohoka K., Takano M., Okano T., Maeda S., Inui K., Hori R. p-Aminohippurate Transport in Rat Renal Brush-Border Membranes: a Potential-Sensitive Transport System and an Anion Exchanger. Biol. Pharm. Bull. 1993; 16: 395–401
  • Russel F.G.M., van der Linden P.E.M., Vermeulen W.G., Heijn M., van Os C.H., van Ginneken C.A.M. Na+ and H+ Gradient-Dependent Transport of p-Aminohippurate in Membrane Vesicles from Dog Kidney Cortex. Biochem. Pharmacol. 1988; 37: 2639–2649
  • Blomstedt J.W., Aronson P.S. pH Gradient-Stimulated Transport of Urate and p-Aminohippurate in Dog Renal Microvillus Membrane Vesicles. J. Clin. Invest. 1980; 65: 931–934
  • Kahn A.M., Aronson P.S. Urate Transport via Anion Exchange in Dog Renal Microvillus Membrane Vesicles. Am. J. Physiol. 1983; 244: F56–F63
  • Steffens T.G., Holohan P.D., Ross C.R. Operational Modes of the Organic Anion Exchanger in Canine Renal Brush-Border Membrane Vesicles. Am. J. Physiol. 1989; 256: F596–F609
  • Bergwerk A.J., Shi X., Ford A.C., Kanai N., Jacquemin E., Burk R.D., Bai S., Novikoff P.M., Stieger B., Meier P.J., Schuster V.L., Wolkoff A.W. Immunologic Distribution of an Organic Anion Transport Protein in Rat Liver and Kidney. Am. J. Physiol. 1996; 271: G231–G238
  • Abe T., Kakyo M., Sakagami H., Tokui T., Nishio T., Tanemoto M., Nomura H., Hebert S.C., Matsuno S., Kondo H., Yawo H. Molecular Characterization and Tissue Distribution of a New Organic Anion Transporter Subtype (oatp3) that Transports Thyroid Hormones and Taurocholate and Comparison with oatp2. J. Biol. Chem. 1998; 273: 22395–22401
  • Masuda S., Saito H., Nonoguchi H., Tomita K., Inui K. mRNA Distribution and Membrane Localization of the OAT-K1 Organic Anion Transporter in Rat Renal Tubules. FEBS Lett. 1997; 407: 127–131
  • Masuda S., Ibaramoto K., Takeuchi A., Saito H., Hashimoto Y., Inui K. Cloning and Functional Characterization of a New Multispecific Organic Anion Transporter, Oat-k2, in Rat Kidney. Mol. Pharmacol. 1999; 55: 743–753
  • Cha S.H., Sekine T., Kusuhara H., Yu E., Kim J.Y., Kim D.K., Sugiyama Y., Kanai Y., Endou H. Molecular Cloning and Characterization of Multispecific Organic Anion Transporter 4 Expressed in the Placenta. J. Biol. Chem. 2000; 275: 4507–4512
  • Walters H.C., Craddock A.L., Fusegawa H., Willingham M.C., Dawson P.A. Expression, Transport Properties, and Chromosomal Location of Organic Anion Transporter Subtype 3. Am. J. Physiol. 2000; 279: G1188–G1200
  • Roch-Ramel F., Guisan B., Schild L. Indirect Coupling of Urate and p-Aminohippurate Transport to Sodium in Human Brush-Border Membrane Vesicles. Am. J. Physiol. 1996; 270: F61–F68
  • Schmitt C., Burckhardt G. p-Aminohippurate/a-Ketoglutarate Exchange in Bovine Renal Brush-Border and Basolateral Membrane Vesicles. Pflügers Arch. 1993; 423: 280–290
  • Martinez F., Manganel M., Montrose-Rafizadeh C., Werner D., Roch-Ramel F. Transport of Urate and p-Aminohippurate in Rabbit Renal Brush-Border Membranes. Am. J. Physiol. 1990; 258: F1145–F1153
  • Werner D., Martinez F., Roch-Ramel F. Urate and p-Aminohippurate Transport in the Brush-Border Membrane of the Pig Kidney. J. Pharmacol. Exp. Ther. 1990; 252: 792–799
  • Van Aubel R.A.M.H., Peters J.G.P., Masereeuw R., van Os C.H., Russel F.G.M. Multidrug Resistance Protein mrp2 Mediates ATP-Dependent Transport of Classic Renal Organic Anion p-Aminohippurate. Am. J. Physiol. 2000; 279: F713–F717
  • Leier I., Hummel-Eisenbeiss J., Cui Y., Keppler D. ATP-Dependent para-Aminohippurate Transport by Apical Multidrug Resistance Protein MRP2. Kidney Int. 2000; 57: 1636–1642
  • Paulusma C.C., Bosma P.J., Zaman G.J.R., Bakker C.T.M., Otter M., Scheffer G.L., Scheper R.J., Borst P., Oude Elferink R.P.J. Congenital Jaundice in Rats with a Mutation in a Multidrug Resistance-Associated Protein Gene. Science 1996; 271: 1126–1128
  • Schaub T.P., Kartenbeck J., Konig J., Vogel O., Witzgall R., Kriz W., Keppler D. Expression of the Conjugate Export Pump Encoded by the mrp2 Gene in the Apical Membrane of Kidney Proximal Tubules. J. Am. Soc. Nephrol. 1997; 8: 1213–1221
  • Van Aubel R.A.M.H., Hartog A., Bindels R.J.M., van Os C.H., Russel F.G.M. Expression and Immunolocalization of Multidrug Resistance Protein 2 in Rabbit Small Intestine. Eur. J. Pharmacol. 2000; 400: 195–198
  • Masereeuw R., Moons M.M., Toomey B.H., Russel F.G.M., Miller D.S. Active Lucifer Yellow Secretion in Renal Proximal Tubule: Evidence for Organic Anion Transport System Crossover. J. Pharmacol. Exp. Ther. 1999; 289: 1104–1111
  • Masereeuw R., Terlouw S.A., van Aubel R.A.M.H., Russel F.G.M., Miller D.S. Endothelin B Receptor-Mediated Regulation of ATP-Driven Drug Secretion in Renal Proximal Tubule. Mol. Pharmacol. 2000; 57: 59–67
  • Bruzzi I., Remuzzi G., Benigni A. Endothelin: a Mediator of Renal Disease Progression. J. Nephrol. 1997; 10: 179–183
  • Hocher B., Reineke C. Thone, Bauer C., Raschack M., Neumayer H.H. The Paracrine Endothelin System: Pathophysiology and Implications in Clinical Medicine. Eur. J. Clin. Chem. Clin. Biochem. 1997; 35: 175–189
  • Clavell A.L., Burnett J.C., Jr. Physiologic and Pathophysiologic Roles of Endothelin in the Kidney. Curr. Opin. Nephrol. Hypertens. 1994; 3: 66–72
  • Terlouw S.A., Masereeuw R., Russel F.G.M., Miller D.S. Nephrotoxicants Induce Endothelin Release and Signaling in Renal Proximal Tubules: Effect on Drug Efflux. Mol. Pharmacol., in press
  • May D.G., Weiner I.M. The Renal Mechanisms for the Excretion of m-Hydroxybenzoic Acid in Cebus Monkeys: Relationship to Urate Transport. J. Pharmacol. Exp. Ther. 1971; 176: 407–417
  • Besseghir K., Roch-Ramel F. Pyrazinoate Transport in the Isolated Perfused Rabbit Proximal Tubule. Pflügers Arch. 1986; 407: 643–648
  • Weiner I.M., Tinker J.P. Pharmacology of Pyrazinamide: Metabolic and Renal Function Related to the Mechanism of Drug Induced Urate Retention. J. Pharmacol. Exp. Ther. 1972; 180: 411–434
  • Corr P.B., May D.G. Renal Mechanisms for the Excretion of Nicotinic Acid. J. Pharmacol. Exp. Ther. 1975; 192: 195–200
  • Kinter W.B. Renal Tubular Transport of Diodrast-I131 and PAH in Necturus: Evidence for Simultaneous Reabsorption and Secretion. Am. J. Physiol. 1959; 196: 1141–1149
  • Ries M., Wenzel U., Daniel H. Transport of Cefadroxil in Rat Kidney Brush-Border Membranes is Mediated by Two Electrogenic H+-Coupled Systems. J. Pharmacol. Exp. Ther. 1994; 271: 1327–1333
  • Liu W., Liang R., Ramamoorthy S., Fei Y.J., Ganapathy M.E., Hediger M.A., Ganapathy V., Leibach F.H. Molecular Cloning of PEPT 2, a New Member of the H+/peptide Cotransporter Family, from Human Kidney. Biochim. Biophys. Acta 1995; 1235: 461–466
  • Ganapathy M.E., Prasad P.D., Mackenzie B., Ganapathy V., Leibach F.H. Interaction of Anionic Cephalosporins with the Intestinal and Renal Peptide Transporters PEPT 1 and PEPT 2. Biochim. Biophys. Acta 1997; 1324: 296–308
  • Ganapathy M.E., Brandsch M., Prasad P.D., Ganapathy V., Leibach F.H. Differential Recognition of beta-Lactam Antibiotics by Intestinal and Renal Peptide Transporters, PEPT 1 and PEPT 2. J. Biol. Chem. 1995; 270: 25672–25677
  • Wenzel U., Thwaites D.T., Daniel H. Stereoselective Uptake of b-Lactam Antibiotics by the Intestinal Peptide Transporter. Br. J. Pharmacol. 1995; 116: 3021–3027
  • Franco R., Centelles J.J., Kinne R.K. Further Characterization of Adenosine Transport in Renal Brush-Border Membranes. Biochim. Biophys. Acta 1990; 1024: 241–248
  • Gutierrez M.M., Giacomini K.M. Substrate Selectivity, Potential Sensitivity and Stoichiometry of Na(+)-Nucleoside Transport in Brush Border Membrane Vesicles from Human Kidney. Biochim. Biophys. Acta 1993; 1149: 202–208
  • Williams T.C., Jarvis S.M. Multiple Sodium-Dependent Nucleoside Transport Systems in Bovine Renal Brush-Border Membrane Vesicles. Biochem. J. 1991; 274: 27–33
  • Cass C.E., Young J.D., Baldwin S.A., Cabrita M.A., Graham K.A., Griffiths M., Jennings L.L., Mackey J.R., Ng A.M., Ritzel M.W., Vickers M.F., Yao S.Y. Nucleoside Transporters of Mammalian Cells. Pharm. Biotechnol. 1999; 12: 313–352
  • Wang J., Su S.F., Dresser M.J., Schaner M.E., Washington C.B., Giacomini K.M. Na(+)-Dependent Purine Nucleoside Transporter from Human Kidney: Cloning and Functional Characterization. Am. J. Physiol. 1997; 273: F1058–F1065
  • Boyde A., Capasso G., Unwin R.J. Conventional and Confocal epi-Reflection and Fluorescence Microscopy of the Rat Kidney In Vivo. Exp. Nephrol. 1998; 6: 398–408
  • Terlouw S.A., Russel F.G.M., Masereeuw R. Metabolite Anion Carriers Mediate the Uptake of the Anionic Drug Fluorescein in Renal Cortical Mitochondria. J. Pharmacol. Exp. Ther. 2000; 292: 968–973
  • Miller D.S., Stewart D.E., Pritchard J.B. Intracellular Compartmentation of Organic Anions Within Renal Cells. Am. J. Physiol. 1993; 264: R882–R890
  • Brown D. Epithelial Cell Polarity: Molecular Mechanisms. Molecular Nephrology, Kidney Fucntion in Health and Disease, D. Schlöndorff, J.V. Bonventre. Marcel Dekker, Inc., New York 1995; 21–32
  • Tojo A., Sekine T., Nakajima N., Hosoyamada M., Kanai Y., Kimura K., Endou H. Immunohistochemical Localization of Multispecific Renal Organic Anion Transporter 1 in Rat Kidney. J. Am. Soc. Nephrol. 1999; 10: 464–471
  • Campbell J.A.H., Bass N.M., Kirsch R.E. Immunohistological Localization of Ligandin in Human Tissues. Cancer 1980; 45: 503–510
  • Litwack G., Ketterer B., Arias I.M. Ligandin: a Hepatic Protein which binds Steroids, Bilirubin, Carcinogens and a Number of Exogenous Organic Anions. Nature 1971; 234: 466–467
  • Sheehan D., Mantle T.J. Evidence for Two Forms of Ligandin (YaYa dimers of Glutathione S-Transferase) in Rat Liver and Kidney. Biochem. J. 1984; 218: 893–897
  • Goldstein E.J., Arias I.M. Interaction of Ligandin with Radiographic Contrast Media. Invest. Radiol. 1976; 11: 594–597
  • Kirsch R., Fleischner G., Kamisaka K., Arias I.M. Structural and Functional Studies of Ligandin, a Major Renal Organic Anion-Binding Protein. J. Clin. Invest. 1975; 55: 1009–1019
  • Pegg D.G., Hook J.B. Glutathione S-Transferases: an Evaluation of Their Role in Renal Organic Anion Transport. J. Pharmacol. Exp. Ther. 1977; 200: 65–74
  • Farah A., Frazer M. Studies on the Renal Tubular Secretion of N1-Methylnicotinamide. J. Pharmacol. Exp. Ther. 1961; 134: 245
  • Rennick B.R. Renal Tubule Transport of Organic Cations. Am. J. Physiol. 1981; 240: F83–F89
  • Ross C.R., Diezi-Chométy F., Roch-Ramel F. Renal Excretion of N1-Methylnicotinamde in the Rat. Am. J. Physiol. 1975; 228: 1641–1645
  • Somogoyi A. New Insights into the Renal Secretion of Drugs. Trends Pharmacol. Sci. 1987; 8: 354–357
  • Torretti J., Weiner I.M., Mudge G.H. Renal Tubular Secretion and Reabsorption of Organic Bases in the Dog. J. Clin. Invest. 1962; 41: 793–804
  • McKinney T.D., Myers P., Speeg K.V., Jr. Cimetidine Secretion by Rabbit Renal Tubules In Vitro. Am. J. Physiol. 1981; 241: F69–F76
  • Besseghir K., Roch-Ramel F. Renal Excretion of Drugs and Other Xenobiotics. Renal Physiol. 1987; 10: 221–241
  • Montrose-Rafizadeh C., Mingard F., Murer H., Roch-Ramel F. Carrier-Mediated Transport of Tetraethylammonium Across Rabbit Renal Basolateral Membrane. Am. J. Physiol. 1987; 257: F243–F251
  • Sokol P.P., McKinney T.D. Mechanism of Organic Cation Transport in Rabbit Renal Basolateral Membrane Vesicles. Am. J. Physiol. 1990; 258: F1599–F1607
  • McKinney T.D., Speeg K.V., Jr. Cimetidine and Procainamide Secretion by Proximal Tubules In Vitro. Am. J. Physiol. 1982; 242: F672–F680
  • Tarloff J.B., Brand P.H. Active Tetraethylammonium Uptake Across the Basolateral Membrane of the Proximal Tubule. Am. J. Physiol. 1986; 251: F141–F149
  • Brändle E., Greven J. Transport of Cimetidine Across the Basolateral Membrane of Rabbit Kidney Proximal Tubules: Characterization of Transport Mechanisms. J. Pharmacol. Exp. Ther. 1991; 258: 1038–1045
  • Hohage H., Querl I.U., Morth D.M., Greven J. The Basolateral Organic Cation Transport System of Rabbit Kidney Proximal Tubules. Influence of Anorganic Anions. J. Pharmacol. Exp. Ther. 1996; 279: 1086–1091
  • Green R.M., Lo K., Sterritt C., Beier J.R. Cloning and Functional Expression of a Mouse Liver Organic Cation Transporter. Hepatology 1999; 29: 1556–1562
  • Mooslehner K.A., Allen N.D. Cloning of the Mouse Organic Cation Transporter 2 Gene,Slc22a2, from an Enhancer-Trap Transgene Integration Locus. Mamm. Genome 1999; 10: 218–224
  • Terashita S., Dresser M.J., Zhang L., Gray A.T., Yost S.C., Giacomini K.M. Molecular Cloning and Functional Expression of a Rabbit Renal Organic Cation Transporter. Biochim. Biophys. Acta 1998; 1369: 1–6
  • Zhang L., Dresser M.J., Gray A.T., Yost S.C., Terashita S., Giacomini K.M. Cloning and Functional Expression of a Human Liver Organic Cation Transporter. Mol. Pharmacol. 1997; 51: 913–921
  • Zhang L., Dresser M.J., Chun J.K., Babbitt P.C., Giacomini K.M. Cloning and Functional Characterization of a Rat Renal Organic Cation Transporter Isoform (rOCT1A). J. Biol. Chem. 1997; 272: 16548–16554
  • Gorboulev V., Ulzheimer J.C., Akhoundova A., Ulzheimer-Teuber I., Karbach U., Quester S., Baumann C., Lang F., Busch A.E., Koepsell H. Cloning and Characterization of Two Human Polyspecific Organic Cation Transporters. DNA Cell Biol. 1997; 16: 871–881
  • Okuda M., Saito H., Urakami Y., Takano M., Inui K. cDNA Cloning and Functional Expression of a Novel Rat Kidney Organic Cation Transporter, OCT2. Biochem. Biophys. Res. Commun. 1996; 224: 500–507
  • Grundemann D., Babin-Ebell J., Martel F., Ording N., Schmidt A., Schomig E. Primary Structure and Functional Expression of the Apical Organic Cation Transporter from Kidney Epithelial LLC-PK1 Cells. J. Biol. Chem. 1997; 272: 10408–10413
  • Mori K., Ogawa Y., Ebihara K., Aoki T., Tamura N., Sugawara A., Kuwahara T., Ozaki S., Mukoyama M., Tashiro K., Tanaka I., Nakao K. Kidney-Specific Expression of a Novel Mouse Organic Cation Transporter-Like Protein. FEBS Lett. 1997; 417: 371–374
  • Sweet D.H., Pritchard J.B. rOCT2 is a Basolateral Potential-Driven Carrier, Not an Organic Cation/Proton Exchanger. Am. J. Physiol. 1999; 277: F890–F898
  • Karbach U., Kricke J., Meyer-Wentrup F., Gorboulev V., Volk C., Loffing-Cueni D., Kaissling B., Bachmann S., Koepsell H. Localization of Organic Cation Transporters OCT1 and OCT2 in Rat Kidney. Am. J. Physiol. 2000; 279: F679–F687
  • Kekuda R., Prasad P.D., Wu X., Wang H., Fei Y.J., Leibach F.H., Ganapathy V. Cloning and Functional Characterization of a Potential-Sensitive, Polyspecific Organic Cation Transporter (OCT3) Most Abundantly Expressed in Placenta. J. Biol. Chem. 1998; 273: 15971–15979
  • Wu X., Huang W., Ganapathy M.E., Wang H., Kekuda R., Conway S.J., Leibach F.H., Ganapathy V. Structure, Function, and Regional Distribution of the Organic Cation Transporter OCT3 in the Kidney. Am. J. Physiol. 2000; 279: F449–F458
  • Hohage H., Morth D.M., Querl I.U., Greven J. Regulation by Protein Kinase C of the Contraluminal Transport System for Organic Cations in Rabbit Kidney S2 Proximal Tubules. J. Pharmacol. Exp. Ther. 1994; 268: 897–901
  • Holohan P.D., Ross C.R. Mechanisms of Organic Cation Transport in Kidney Plasma Membrane Vesicles: 1. Countertransport Studies. J. Pharmacol. Exp. Ther. 1980; 215: 191–197
  • Holohan P.D., Ross C.R. Mechanisms of Organic Cation Transport in Kidney Plasma Membrane Vesicles: 2. dpH Studies. J. Pharmacol. Exp. Ther. 1981; 216: 294–298
  • Sokol P.P., Holohan P.D., Grass S.M., Ross C.R. Proton-Coupled Organic Cation Transport in Renal Brush-Border Membrane Vesicles. Biochim. Biophys. Acta 1988; 940: 209–218
  • Warnock D.G., Reenstra W.W., Yee V.J. Na+/H+ Antiporter of Brush Border Vesicles: Studies with Acridine Orange. Am. J. Physiol. 1982; 242: F733–F739
  • Gilsdorf J.S., Rebbeor J.F., Holohan P.D. Evidence that the Organic Cation/H+ Exchanger in the Brush Border Membrane of Dog Kidney is a 41-kDa Protein. J. Pharmacol. Exp. Ther. 1997; 280: 1043–1050
  • Kimura M., Nabekura T., Katsura T., Takano M., Hori R. Identification of Organic Cation Transporter in Rat Renal Brush-Border Membrane by Photoaffinity Labeling. Biol. Pharm. Bull. 1995; 18: 388–395
  • Hsyu P.-H., Gisclon L.G., Hui A.C., Giacomini K.M. Interactions of Organic Anions with the Organic Cation Transporter in Renal BBMV. Am. J. Physiol. 1988; 254: F56–F61
  • Thibaut F., Tsuruo T., Hamada H., Gottesman M.M., Pastan I., Willingham M.C. Cellular Localization of the Multidrug Resistance Gene Product P-Glycoprotein in Normal Human Tissues. Proc. Natl. Acad. Sci. USA 1987; 84: 7735–7738
  • Ford J.M., Hait W.N. Pharmacology of Drugs that Alter Multidrug Resistance in Cancer. Pharmacol. Rev. 1990; 42: 155–199
  • De Lannoy I.A.M., Koren G., Klein J., Charuk J., Silverman M. Cyclosporin and Quinidine Inhibition of Renal Digoxin Excretion: Evidence for Luminal Secretion of Digoxin. Am. J. Physiol. 1992; 263: F613–F622
  • Hori R., Okamura N., Aiba T., Tanigawara Y. Role of P-Glycoprotein in Renal Tubular Secretion of Digoxin in the Isolated Perfused Rat Kidney. J. Pharmacol. Exp. Ther. 1993; 266: 1620–1625
  • Holohan P.D., White K.E., Sokol P.P., Rebbeor J. Photoaffinity Labeling of the Organic Cation/H+ Exchanger in Renal Brush Border Membrane Vesicles. J. Biol. Chem. 1992; 267: 13513–13519
  • Miller D.S. Daunomycin Secretion by Killifish Renal Proximal Tubules. Am. J. Physiol. 1995; 269: R370–R379
  • Miller D.S., Sussman C.R., Renfro J.L. Protein Kinase C Regulation of p-Glycoprotein-Mediated Xenobiotic Secretion in Renal Proximal Tubule. Am. J. Physiol. 1998; 275: F785–F795
  • Hsu S.I., Lothstein L., Horwitz S.B. Differential Overexpression of Three mdr Gene Family Members in Multidrug-Resistant J774.2 Mouse Cells. Evidence that Distinct p-Glycoprotein Precursors are Encoded by Unique mdr Genes. J. Biol. Chem. 1989; 264: 12053–12062
  • Chin J.E., Soffir R., Noonan K.E., Choi K., Roninson I.B. Structure and Expression of the Human MDR (P-Glycoprotein) Gene Family. Mol. Cell Biol. 1989; 9: 3808–3820
  • Cvetkovic M., Leake B., Fromm M.F., Wilkinson G.R., Kim R.B. OATP and P-Glycoprotein Transporters Mediate the Cellular Uptake and Excretion of Fexofenadine. Drug Metab. Dispos. 1999; 27: 866–871
  • Dubuisson C., Cresteil D., Desrochers M., Decimo D., Hadchouel M., Jacquemin E. Ontogenic Expression of the Na(+)-Independent Organic Anion Transporting Polypeptide (oatp) in Rat Liver and Kidney. J. Hepatol. 1996; 25: 932–940
  • Bossuyt X., Muller M., Hagenbuch B., Meier P.J. Polyspecific Drug and Steroid Clearance by an Organic Anion Transporter of Mammalian Liver. J. Pharmacol. Exp. Ther. 1996; 276: 891–896
  • Tamai I., Yabuuchi H., Nezu J., Sai Y., Oku A., Shimane M., Tsuji A. Cloning and Characterization of a Novel Human pH-Dependent Organic Cation Transporter, OCTN1. FEBS Lett. 1997; 419: 107–111
  • Tamai I., Ohashi R., Nezu J., Yabuuchi H., Oku A., Shimane M., Sai Y., Tsuji A. Molecular and Functional Identification of Sodium Ion-Dependent, High Affinity Human Carnitine Transporter OCTN2. J. Biol. Chem. 1998; 273: 20378–20382
  • Tamai I., Ohashi R., Nezu J., Sai Y., Kobayashi D., Oku A., Shimane M., Tsuji A. Molecular and Functional Characterization of Organic Cation/Carnitine Transporter Family in Mice. J. Biol. Chem. 2000; 275: 40064–40072
  • Ohashi R., Tamai I., Nezu J.J., Nikaido H., Hashimoto N., Oku A., Sai Y., Shimane M., Tsuji A. Molecular and Physiological Evidence for Multifunctionality of Carnitine/Organic Cation Transporter OCTN2. Mol. Pharmacol. 2001; 59: 358–366
  • Wright S.H., Wunz T.M., Wunz T.P., choline A. Transporter in Renal Brush-Border Membrane Vesicles: Energetics and Structural Specificity. J. Membr. Biol. 1992; 126: 51–65
  • Wright S.H., Wunz T.M. Transport of Tetraethylammonium by Rabbit Renal Burh-Border and Basolateral Vesicles. Am. J. Physiol. 1987; 253: F1040–F1050
  • Berndt W.O. Organic Base Transport: a Comparative Study. Pharmacology 1981; 22: 251–262
  • Johnson L.V., Walsh M.L., Bockus B.J., Chen L.B. Monitoring of Relative Mitochondrial Membrane Potential in Living Cells by Fluorescence Microscopy. J. Cell Biol. 1981; 88: 526–535
  • Rogers K.S., Higgins E.S. Lipophilic Interactions of Organic Cations with Mitochondrial Inner Membranes During Respiratory Control. J. Biol. Chem. 1973; 248: 7142–7148
  • Stachon A., Schlatter E., Hohage H. Dynamic Monitoring of Organic Cation Transport Processes by Fluorescence Measurements in LLC-PK1 Cells. Cell. Physiol. Biochem. 1996; 6: 72–81
  • Mellman I., Fuchs R., Helenius A. Acidification of the Endocytic and Exocytic Pathways. Annu. Rev. Biochem. 1986; 55: 663–700
  • Pritchard J.B., Sykes D.B., Walden R., Miller D.S. ATP-Dependent Transport of Tetraethylammonium by Endosomes Isolated from Rat Renal Cortex. Am. J. Physiol. 1994; 266: F966–F976
  • Besseghir K., Mosig D., Roch-Ramel F. Transport of the Organic Cation N-Methylnicotinamide by the Rabbit Proximal Tubule. I. Accumulation in the Isolated Nonperfused Tubule. J. Pharmacol. Exp. Ther. 1990; 253: 444–460
  • Melby E.L., Prydz K., Olsnes S., Sandveg K. Effect of Monensin on Ricin and Fluid Phase Transport in Polarized MDCK Cells. J. Cell. Biochem. 1991; 47: 251–260
  • Chennavasin P., Seiwell R., Brater D.C., Liang W.M.M. Pharmacodynamic Analysis of the Furosemide-Probenecid Interaction in Man. Kidney Int. 1979; 16: 187–195
  • Masereeuw R., Moons M.M., Russel F.G.M. Saturable Accumulation and Diuretic Activity of Hydrochlorothiazide in the Isolated Perfused Rat Kidney. Pharmacology 1997; 54: 33–42
  • Leitman P.S., Smith C.R. Aminoglycoside Nephrotoxicity in Humans. J. Infect. Dis. 1983; 5: S284–S293
  • Finn J.T., Cohen L.H., Steinmetz P.R. Acidifying Defect Induced by Amphotericin B: Comparison of Bicarbonate and Hydrogen Ion Permeabilities. Kidney Int. 1977; 11: 261–266
  • Hoeprich P.D. Chemotherapy of Systemic Fungal Diseases. Ann. Rev. Pharmacol. Toxicol. 1978; 18: 205–231
  • Sabra R., Branch R.A. Amphotericin B Nephrotoxicity. Drug Safety 1990; 5: 94–108
  • Humes H.D., Weinberg J.M. Toxic Nephropathies. The Kidney, B.M. Brenner, F.C. Rector, Jr. W.B. Saunders Company, Philadelphia 1986; 1491–1532
  • Walker R.J., Duggin G.G. Cellular Mechanisms of Drug Nephrotoxicity. The Kidney: Physiology and Pathophysiology, D.W. Seldin, G. Giebisch. Raven Press, Ltd., New York 1992; 3571–3595
  • Nierenberg D.W. Drug Inhibition of Penicillin Tubular Secretion: Concordance Between In Vitro and Clinical Findings. J. Pharmacol. Exp. Ther. 1987; 240: 712–716
  • van Crugten J., Bochner F., Keal J., Somogoyi A. Studies with Anionic, Cationic and Zwitterionic Drugs. J. Pharmacol. Exp. Ther. 1986; 236: 481–487
  • King H.W., Macfarlane A.W., Graham R.M., Verbov J.L. Near Fatal Drug Interactions with Methotrexate Given for Psoriasis. Br. Med. J. 1987; 295: 752–753
  • Kremer J.M., Hamilton R.A. The Effects of Nonsteroidal Antiinflammatory Drugs on Methotrexate (MTX) Pharmacokinetics: Impairment of Renal Clearance of MTX at Weekly Maintenance Doses But Not at 7.5 mg. J. Rheumatol. 1995; 22: 2072–2077
  • Maiche A.G. Acute Renal Failure Due to Concommitant Action of Methotrexate and Indomethacin. Lancet 1986; 1390
  • Singh R.R., Malaviya A.N., Pandley J.N., Guleria J.S. Fatal Interaction Between Methotrexate and Naproxen. Lancet 1986; 1390
  • Steele T.H. Urate Secretion in Man: The Pyrazinamide Suppression Test. Ann. Intern. Med. 1973; 79: 734–737
  • Burgess E., Blair A., Krichman K., Cutler R.E. Inhibition of Renal Creatinine Secretion in Humans. Renal Physiol. 1982; 5: 27–30
  • Shouval D., Ligumsky M., Ben-Ishay D. Effect of co-Trimoxazole on Normal Creatinine Clearance. Lancet 1978; 1: 244–245
  • Reidenberg M.M., Drayer D.E. Drug Therapy in Renal Failure. Ann. Rev. Pharmacol. Toxicol. 1980; 20: 45–54
  • Barrett B.J. Contrast Nephrotoxicity. J. Am. Soc. Nephrol. 1994; 5: 125–137
  • Oymak O. Contrast Media Induced Irreversible Acute Renal Failure in a Patient Treated with Intraperitoneal Cisplatin. Clin. Nephrol. 1995; 44: 135–136
  • Heyman S.N., Brezis M., Reubinoff C.A., Greenfeld Z., Lechene C., Epstein F.H., Rosen S. Acute Renal Failure with Selective Medullary Injury in the Rat. J. Clin. Invest. 1988; 82: 401–412
  • Heyman S.N., Brezis M., Epstein F.H., Spokes K., Silva P., Rosen S. Early Renal Medullary Hypoxic Injury from Radiocontrast and Indomethacin. Kidney Int. 1991; 40: 632–642
  • Vari R.C., Natarajian L.A., Whitescarver S.A., Jackson B.A., Ott C.M. Induction Prevention and Mechanisms of Contrast Media Induced Acute Renal Failure. Kidney Int. 1988; 33: 699–707
  • Somogyi A., McLean A., Heinzow B. Cimetidine-Procainamide Pharmacokinetic Interaction in Man: Evidence of Competition for Tubular Secretion of Basic Drugs. Eur. J. Clin. Pharmacol. 1983; 25: 339–345
  • Hilbrands L.B., Artz M.A., Wetzels J.F., Koene R.A. Cimetidine Improves the Reliability of Creatinine as a Marker of Glomerular Filtration. Kidney Int. 1991; 40: 1171–1176
  • Marcen R., Serrano P., Teruel J.L., Rivera M.E., Mitjavila M., Navarro J., Orofino L., Sabater J., Ortuno J. Oral Cimetidine Improves the Accuracy of Creatinine Clearance in Transplant Patients on Cyclosporine. Transplant Proc. 1994; 26: 2624–2625
  • Roubenoff R., Drew H., Moyer M., Petri M., Whiting-O'Keefe Q., Hellmann D.B. Oral Cimetidine Improves the Accuracy and Precision of Creatinine Clearance in Lupus Nephritis. Ann. Intern. Med. 1990; 113: 501–506
  • van Acker B.A., Koomen G.C., Koopman M.G., de Waart D.R., Arisz L. Creatinine Clearance During Cimetidine Administration for Measurement of Glomerular Filtration Rate. Lancet 1992; 340: 1326–1329
  • Abraham P.A., Opsahl J.A., Halstenson C.E., Chremos A.N., Matzke G.R., Keane W.F. The Effect of Famotidine on Renal Function in Patients with Renal Insufficiency. Br. J. Clin. Pharmacol. 1987; 24: 385–389
  • Klotz U., Arvela P., Rosenkranz B. Famotidine, a New H2-Receptor Antagonist, Does Not Affect Hepatic Elimination of Diazepam or Tubular Secretion of Procainamide. Eur. J. Clin. Pharmacol. 1985; 28: 671–675
  • Sommers D.K., Schoeman H.S. Drug Interactions with Urate Excretion in Man. Eur. J. Clin. Pharmacol. 1987; 32: 499–502
  • Turnheim K., Krivanek P., Oberbauer R. Pharmacokinetics and Pharmacodynamics of Allopurinol in Elderly and Young Subjects. Br. J. Clin. Pharmacol. 1999; 48: 501–509
  • Heuberger W., Berardi S., Jacky E., Pey P., Krahenbuhl S. Increased Urinary Excretion of Carnitine in Patients Treated with Cisplatin. Eur. J. Clin. Pharmacol. 1998; 54: 503–508
  • Hosoyamada M., Sekine T., Kanai Y., Endou H. Molecular Cloning and Functional Expression of a Multispecific Organic Anion Transporter from Human Kidney. Am. J. Physiol. 1999; 276: F122–F128
  • Wada S., Tsuda M., Sekine T., Cha S.H., Kimura M., Kanai Y., Endou H. Rat Multispecific Organic Anion Transporter 1 (rOAT1) Transports Zidovudine, Acyclovir, and Other Antiviral Nucleoside Analogs. J. Pharmacol. Exp. Ther. 2000; 294: 844–849
  • Tsuda M., Sekine T., Takeda M., Cha S.H., Kanai Y., Kimura M., Endou H. Transport of Ochratoxin A by Renal Multispecific Organic Anion Transporter 1. J. Pharmacol. Exp. Ther. 1999; 289: 1301–1305
  • Apiwattanakul N., Sekine T., Chairoungdua A., Kanai Y., Nakajima N., Sophasan S., Endou H. Transport Properties of Nonsteroidal Anti-Inflammatory Drugs by Organic Anion Transporter 1 Expressed in Xenopus Laevis Oocytes. Mol. Pharmacol. 1999; 55: 847–854
  • Sekine T., Cha S.H., Tsuda M., Apiwattanakul N., Nakajima N., Kanai Y., Endou H. Identification of Multispecific Organic Anion Transporter 2 Expressed Predominantly in the Liver. FEBS Lett. 1998; 429: 179–182
  • Kamisako T., Leier I., Cui Y., Konig J., Buchholz U., Hummel-Eisenbeiss J., Keppler D. Transport of Monoglucuronosyl and Bisglucuronosyl Bilirubin by Recombinant Human and Rat Multidrug Resistance Protein 2. Hepatology 1999; 30: 485–490
  • Cui Y., Konig J., Buchholz J.K., Spring H., Leier I., Keppler D. Drug Resistance and ATP-Dependent Conjugate Transport Mediated by the Apical Multidrug Resistance Protein, MRP2, Permanently Expressed in Human and Canine Cells. Mol. Pharmacol. 1999; 55: 929–937
  • Cantz T., Nies A.T., Brom M., Hofmann A.F., Keppler D. MRP2, a Human Conjugate Export Pump, Is Present and Transports Fluo 3 into Apical Vacuoles of Hep G2 cells. Am. J. Physiol. 2000; 278: G522–G531
  • Ishikawa T., Muller M., Klunemann C., Schaub T., Keppler D. ATP-Dependent Primary Active Transport of Cysteinyl Leukotrienes Across Liver Canalicular Membrane. Role of the ATP-Dependent Transport System for Glutathione S-Conjugates. J. Biol. Chem. 1990; 265: 19279–19286
  • Kusuhara H., Han Y.H., Shimoda M., Kokue E., Suzuki H., Sugiyama Y. Reduced Folate Derivatives Are Endogenous Substrates for cMOAT in Rats. Am. J. Physiol. 1998; 38: G789–G796
  • Paulusma C.C., van Geer M.A., Evers R., Heijn M., Ottenhoff R., Borst P., Oude Elferink R.P.J. Canalicular Multispecific Organic Anion Transporter Multidrug Resistance Protein 2 Mediates Low-Affinity Transport of Reduced Glutathione. Biochem. J. 1999; 338: 393–401
  • Nies A.T., Cantz T., Brom M., Leier I., Keppler D. Expression of the Apical Conjugate Export Pump, Mrp2, in the Polarized Hepatoma Cell Line, WIF-B. Hepatology 1998; 28: 1332–1340
  • Akita H., Suzuki H., Ito K., Kinoshita S., Sato N., Takikawa H., Sugiyama Y. Characterization of Bile Acid Transport Mediated by Multidrug Resistance Associated Protein 2 and Bile Salt Export Pump. Biochim. Biophys. Acta 2001; 1511: 7–16
  • Akhteruzzaman S., Kato Y., Hisaka A., Sugiyama Y. Primary Active Transport of Peptidic Endothelin Antagonists by Rat Hepatic Canalicular Membrane. J. Pharmacol. Exp. Ther. 1999; 288: 575–581
  • Ito K., Suzuki H., Hirohashi T., Kume K., Shimizu T., Sugiyama Y. Functional Analysis of a Canalicular Multispecific Organic Anion Transporter Cloned from Rat Liver. J. Biol. Chem. 1998; 273: 1684–1688
  • Yamazaki M., Akiyama S., Ni'inuma K., Nishigaki R., Sugiyama Y. Biliary Excretion of Pravastatin in Rats: Contribution of the Excretion Pathway Mediated by Canalicular Multispecific Organic Anion Transporter. Drug Metab. Dispos. 1997; 25: 1123–1129
  • Masuda M., I'izuka Y., Yamazaki M., Nishigaki R., Kato Y., Ni'inuma K., Suzuki H., Sugiyama Y. Methotrexate is Excreted into the Bile by Canalicular Multispecific Organic Anion Transporter in Rats. Cancer Res. 1997; 57: 3506–3510
  • Niinuma K., Takenaka O., Horie T., Kobayashi K., Kato Y., Suzuki H., Sugiyama Y. Kinetic Analysis of the Primary Active Transport of Conjugated Metabolites Across the Bile Canalicular Membrane: Comparative Study of S-(2,4-Dinitrophenyl)-Glutathione and 6-Hydroxy-5,7-Dimethyl-2- Methylamino-4-(3-Pyridylmethyl)Benzothiazole Glucuronide. J. Pharmacol. Exp. Ther. 1997; 282: 866–872
  • Ishizuka H., Konno K., Naganuma H., Sasahara K., Kawahara Y., Niinuma K., Suzuki H., Sugiyama Y. Temocaprilat, a Novel Angiotensin-Converting Enzyme Inhibitor, Is Excreted in Bile via an ATP-Dependent Active Transporter (cMOAT) That Is Deficient in Eisai Hyperbilirubinemic Mutant Rats (EHBR). J. Pharmacol. Exp. Ther. 1997; 280: 1304–1311
  • Madon J., Hagenbuch B., Landmann L., Meier P.J., Stieger B. Transport Function and Hepatocellular Localization of mrp6 in Rat Liver. Mol. Pharmacol. 2000; 57: 634–641
  • Jedlitschky G., Leier I., Buchholz U., Hummel-Eisenbeiss J., Burchell B., Keppler D. ATP-Dependent Transport of Bilirubin Glucuronides by the Multidrug Resistance Protein MRP1 and Its Hepatocyte Canalicular Isoform MRP2. Biochem. J. 1997; 327: 305–310
  • Muraoka I., Hasegawa T., Nadai M., Wang L., Haghgoo S., Tagaya O., Nabeshima T. Biliary and Renal Excretions of Cefpiramide in EISAI Hyperbilirubinemic Rats. Antimicrob. Agents Chemother. 1995; 39: 70–74
  • Oude Elferink R.P., Jansen P.L. The Role of the Canalicular Multispecific Organic Anion Transporter in the Disposal of Endo- and Xenobiotics. Pharmacol. Ther. 1994; 64: 77–97
  • Xiong H., Turner K.C., Ward E.S., Jansen P.L., Brouwer K.L. Altered Hepatobiliary Disposition of Acetaminophen Glucuronide in Isolated Perfused Livers from Multidrug Resistance-Associated Protein 2-Deficient TR(−) Rats. J. Pharmacol. Exp. Ther. 2000; 295: 512–518
  • Kouzuki H., Suzuki H., Sugiyama Y. Pharmacokinetic Study of the Hepatobiliary Transport of Indomethacin. Pharm. Res. 2000; 17: 432–438
  • van Aubel R.A.M.H., Koenderink J.B., Peters J.G.P., van Os C.H., Russel F.G.M. Mechanisms and Interaction of Vinblastine and Reduced Glutathione Transport in Membrane Vesicles by the Rabbit Multidrug Resistance Protein Mrp2 Expressed in Insect Cells. Mol. Pharmacol. 1999; 56: 714–719
  • Eckhardt U., Schroeder A., Stieger B., Hochli M., Landmann L., Tynes R., Meier P.J., Hagenbuch B. Polyspecific Substrate Uptake by the Hepatic Organic Anion Transporter Oatp1 in Stably Transfected CHO Cells. Am. J. Physiol. 1999; 276: G1037–G1042
  • Friesema E.C., Docter R., Moerings E.P., Stieger B., Hagenbuch B., Meier P.J., Krenning E.P., Hennemann G., Visser T.J. Identification of Thyroid Hormone Transporters. Biochem. Biophys. Res. Commun. 1999; 254: 497–501
  • Ishizuka H., Konno K., Naganuma H., Nishimura K., Kouzuki H., Suzuki H., Stieger B., Meier P.J., Sugiyama Y. Transport of Temocaprilat into Rat Hepatocytes: Role of Organic Anion Transporting Polypeptide. J. Pharmacol. Exp. Ther. 1998; 287: 37–42
  • Kouzuki H., Suzuki H., Stieger B., Meier P.J., Sugiyama Y. Characterization of the Transport Properties of Organic Anion Transporting Polypeptide 1 (oatp1) and Na(+)/Taurocholate Cotransporting Polypeptide (Ntcp): Comparative Studies on the Inhibitory Effect of their Possible Substrates in Hepatocytes and cDNA-Transfected COS-7 Cells. J. Pharmacol. Exp. Ther. 2000; 292: 505–511
  • Li L., Lee T.K., Meier P.J., Ballatori N. Identification of Glutathione as a Driving Force and Leukotriene C4 as a Substrate for oatp1, the Hepatic Sinusoidal Organic Solute Transporter. J. Biol. Chem. 1998; 273: 16184–16191
  • Kanai N., Lu R., Bao Y., Wolkoff A.W., Vore M., Schuster V.L. Estradiol 17 beta-d-Glucuronide Is a High-Affinity Substrate for oatp Organic Anion Transporter. Am. J. Physiol. 1996; 270: F326–F331
  • Kanai N., Lu R., Bao Y., Wolkoff A.W., Schuster V.L. Transient Expression of oatp Organic Anion Transporter in Mammalian Cells: Identification of Candidate Substrates. Am. J. Physiol. 1996; 270: F319–F325
  • Abu-Zahra T.N., Wolkoff A.W., Kim R.B., Pang K.S. Uptake of Enalapril and Expression of Organic Anion Transporting Polypeptide 1 in Zonal, Isolated Rat Hepatocytes. Drug Metab. Dispos. 2000; 28: 801–806
  • Pang K.S., Wang P.J., Chung A.Y., Wolkoff A.W. The Modified Dipeptide, Enalapril, an Angiotensin-Converting Enzyme Inhibitor, Is Transported by the Rat Liver Organic Anion Transport Protein. Hepatology 1998; 28: 1341–1346
  • Masuda S., Saito H., Inui K. Interactions of Nonsteroidal Anti-Inflammatory Drugs with Rat Renal Organic Anion Transporter, OAT-K1. J. Pharmacol. Exp. Ther. 1997; 283: 1039–1042
  • Saito H., Masuda S., Inui K. Cloning and Functional Characterization of a Novel Rat Organic Anion Transporter Mediating Basolateral Uptake of Methotrexate in the Kidney. J. Biol. Chem. 1996; 271: 20719–20725
  • Fang X., Parkinson F.E., Mowles D.A., Young J.D., Cass C.E. Functional Characterization of a Recombinant Sodium-Dependent Nucleoside Transporter with Selectivity for Pyrimidine Nucleosides (cNT1rat) by Transient Expression in Cultured Mammalian Cells. Biochem. J. 1996; 317(2)457–465
  • Huang Q.Q., Harvey C.M., Paterson A.R., Cass C.E., Young J.D. Functional Expression of Na(+)-Dependent Nucleoside Transport Systems of Rat Intestine in Isolated Oocytes of Xenopus laevis. Demonstration that Rat Jejunum Expresses the Purine-Selective System N1 (cif) and a Second, Novel System N3 Having Broad Specificity for Purine and Pyrimidine Nucleosides. J. Biol. Chem. 1993; 268: 20613–20619
  • Ritzel M.W., Yao S.Y., Huang M.Y., Elliott J.F., Cass C.E., Young J.D. Molecular Cloning and Functional Expression of cDNAs Encoding a Human Na+-Nucleoside Cotransporter (hCNT1). Am. J. Physiol. 1997; 272: C707–C714
  • Yao S.Y., Ng A.M., Ritzel M.W., Gati W.P., Cass C.E., Young J.D. Transport of Adenosine by Recombinant pu. Mol. Pharmacol. 1996; 50: 1529–1535
  • Yao S.Y., Cass C.E., Young J.D. Transport of the Antiviral Nucleoside Analogs 3′-Azido-3′-Deoxythymidine and 2′,3′-Dideoxycytidine by a Recombinant Nucleoside Transporter (rCNT) Expressed in Xenopus laevis Oocytes. Mol. Pharmacol. 1996; 50: 388–393
  • Ritzel M.W., Yao S.Y., Ng A.M., Mackey J.R., Cass C.E., Young J.D. Molecular Cloning, Functional Expression and Chromosomal Localization of a cDNA Encoding a Human Na+/Nucleoside Cotransporter (hCNT2) Selective for Purine Nucleosides and Uridine. Mol. Membr. Biol. 1998; 15: 203–211
  • Che M., Ortiz D.F., Arias I.M. Primary Structure and Functional Expression of a cDNA Encoding the Bile Canalicular, Purine-Specific Na(+)-Nucleoside Cotransporter. J. Biol. Chem. 1995; 270: 13596–13599
  • Schaner M.E., Wang J., Zevin S., Gerstin K.M., Giacomini K.M. Transient Expression of a Purine-Selective Nucleoside Transporter (SPNTint) in a Human Cell Line (HeLa). Pharm. Res. 1997; 14: 1316–1321
  • Balimane P.V., Tamai I., Guo A., Nakanishi T., Kitada H., Leibach F.H., Tsuji A., Sinko P.J. Direct Evidence for Peptide Transporter (PepT1)-Mediated Uptake of a Nonpeptide Prodrug, Valacyclovir. Biochem. Biophys. Res. Commun. 1998; 250: 246–251
  • Ganapathy M.E., Huang W., Wang H., Ganapathy V., Leibach F.H. Valacyclovir: a Substrate for the Intestinal and Renal Peptide Transporters PEPT1 and PEPT2. Biochem. Biophys. Res. Commun. 1998; 246: 470–475
  • Doring F., Walter J., Will J., Focking M., Boll M., Amasheh S., Clauss W., Daniel H. Delta-Aminolevulinic Acid Transport by Intestinal and Renal Peptide Transporters and Its Physiological and Clinical Implications. J. Clin. Invest. 1998; 101: 2761–2767
  • Terada T., Saito H., Mukai M., Inui K. Recognition of beta-Lactam Antibiotics by Rat Peptide Transporters, PEPT1 and PEPT2, in LLC-PK1 Cells. Am. J. Physiol. 1997; 273: F706–F711
  • Terada T., Sawada K., Irie M., Saito H., Hashimoto Y., Inui K. Structural Requirements for Determining the Substrate Affinity of Peptide Transporters PEPT1 and PEPT2. Pflugers Arch. 2000; 440: 679–684
  • Han H., De Vrueh R.L., Rhie J.K., Covitz K.M., Smith P.L., Lee C.P., Oh D.M., Sadee W., Amidon G.L. 5′-Amino Acid Esters of Antiviral Nucleosides, Acyclovir, and AZT Are Absorbed by the Intestinal PEPT1 Peptide Transporter. Pharm. Res. 1998; 15: 1154–1159
  • Merlin D., Steel A., Gewirtz A.T., Si-Tahar M., Hediger M.A., Madara J.L. hPepT1-Mediated Epithelial Transport of Bacteria-Derived Chemotactic Peptides Enhances Neutrophil–Epithelial Interactions. J. Clin. Invest. 1998; 102: 2011–2018
  • Tamai I., Nakanishi T., Nakahara H., Sai Y., Ganapathy V., Leibach F.H., Tsuji A. Improvement of l-Dopa Absorption by Dipeptidyl Derivation, Utilizing Peptide Transporter PepT1. J. Pharm. Sci. 1998; 87: 1542–1546
  • Meredith D., Temple C.S., Guha N., Sword C.J., Boyd C.A., Collier I.D., Morgan K.M., Bailey P.D. Modified Amino Acids and Peptides as Substrates for the Intestinal Peptide Transporter PepT1. Eur. J. Biochem. 2000; 267: 3723–3728
  • Temple C.S., Boyd C.A. Proton-Coupled Oligopeptide Transport by Rat Renal Cortical Brush Border Membrane Vesicles: a Functional Analysis Using ACE Inhibitors to Determine the Isoform of the Transporter. Biochim. Biophys. Acta 1998; 1373: 277–281
  • Wenzel U., Gebert I., Weintraut H., Weber W.M., Clauss W., Daniel H. Transport Characteristics of Differently Charged Cephalosporin Antibiotics in Oocytes Expressing the Cloned Intestinal Peptide Transporter PepT1 and in Human Intestinal Caco-2 Cells. J. Pharmacol. Exp. Ther. 1996; 277: 831–839
  • Busch A.E., Quester S., Ulzheimer J.C., Waldegger S., Gorboulev V., Arndt P., Lang F., Koepsell H. Electrogenic Properties and Substrate Specificity of the Polyspecific Rat cation Transporter rOCT1. J. Biol. Chem. 1996; 271: 32599–32604
  • Busch A.E., Quester S., Ulzheimer J.C., Gorboulev V., Akhoundova A., Waldegger S., Lang F., Koepsell H. Monoamine Neurotransmitter Transport Mediated by the Polyspecific Cation Transporter rOCT1. FEBS Lett. 1996; 395: 153–156
  • Busch A.E., Karbach U., Miska D., Gorboulev V., Akhoundova A., Volk C., Arndt P., Ulzheimer J.C., Sonders M.S., Baumann C., Waldegger S., Lang F., Koepsell H. Human Neurons Express the Polyspecific Cation Transporter hOCT2, Which Translocates Monoamine Neurotransmitters, Amantadine, and Memantine. Mol. Pharmacol. 1998; 54: 342–352
  • Wu X., George R.L., Huang W., Wang H., Conway S.J., Leibach F.H., Ganapathy V. Structural and Functional Characteristics and Tissue Distribution Pattern of Rat OCTN1, an Organic Cation Transporter, Cloned from Placenta. Biochim. Biophys. Acta 2000; 1466: 315–327
  • Wu X., Prasad P.D., Leibach F.H., Ganapathy V. cDNA Sequence, Transport Function, and Genomic Organization of Human OCTN2, a New Member of the Organic Cation Transporter Family. Biochem. Biophys. Res. Commun. 1998; 246: 589–595
  • Fisher G.A., Lum B.L., Hausdorff J., Sikic B.I. Pharmacological Considerations in the Modulation of Multidrug Resistance. Eur. J. Cancer 1996; 32A: 1082–1088
  • Pauli-Magnus C., Murdter T., Godel A., Mettang T., Eichelbaum M., Klotz U., Fromm M.F. P-Glycoprotein-Mediated Transport of Digitoxin, alpha-Methyldigoxin and beta-Acetyldigoxin. Naunyn Schmiedebergs Arch. Pharmacol. 2001; 363: 337–343
  • Weaver J.L., Szabo G., Jr, Pine P.S., Jr, Gottesman M.M., Jr, Goldenberg S., Jr, Aszalos A., Jr. The Effect of Ion Channel Blockers, Immunosuppressive Agents, and Other Drugs on the Activity of the Multi-Drug Transporter. Int. J. Cancer 1993; 54: 456–461
  • Pauli-Magnus C., von Richter O., Burk O., Ziegler A., Mettang T., Eichelbaum M., Fromm M.F. Characterization of the Major Metabolites of Verapamil as Substrates and Inhibitors of P-Glycoprotein. J. Pharmacol. Exp. Ther. 2000; 293: 376–382
  • Huang L., Hoffman T., Vore M. Adenosine Triphosphate-Dependent Transport of Estradiol-17beta(beta-d-Glucuronide) in Membrane Vesicles by MDR1 Expressed in Insect Cells. Hepatology 1998; 28: 1371–1377
  • Hirsch-Ernst K.I., Ziemann C., Schmitz-Salue C., Foth H., Kahl G.F. Modulation of P-Glycoprotein and mdr1b mRNA Expression by Growth Factors in Primary Rat Hepatocyte Culture. Biochem. Biophys. Res. Commun. 1995; 215: 179–185
  • Schinkel A.H., Mayer U., Wagenaar E., Mol C.A., van Deemter L., Smit J.J., van der Valk M.A., Voordouw A.C., Spits H., van Tellingen O., Zijlmans J.M., Fibbe W.E., Borst P. Normal Viability and Altered Pharmacokinetics in Mice Lacking mdr1-Type (Drug-Transporting) P-Glycoproteins. Proc. Natl. Acad. Sci. USA 1997; 94: 4028–4033
  • van Asperen J., Schinkel A.H., Beijnen J.H., Nooijen W.J., Borst P., van Tellingen O. Altered Pharmacokinetics of Vinblastine in Mdr1a P-Glycoprotein-Deficient Mice. J. Natl. Cancer Inst. 1996; 88: 994–999
  • Schinkel A.H., Wagenaar E., van Deemter L., Mol C.A., Borst P. Absence of the mdr1a P-Glycoprotein in Mice Affects Tissue Distribution and Pharmacokinetics of Dexamethasone, Digoxin, and Cyclosporin A. J. Clin. Invest. 1995; 96: 1698–1705
  • de Lange E.C., de Bock G., Schinkel A.H., De Boer A.G., Breimer D.D. BBB transport and P-Glycoprotein Functionality Using MDR1A (−/−) and Wild-Type Mice. Total Brain versus Microdialysis Concentration Profiles of Rhodamine-123. Pharm. Res. 1998; 15: 1657–1665
  • Tsuruoka S., Sugimoto K.I., Fujimura A., Imai M., Asano Y., Muto S. P-Glycoprotein-Mediated Drug Secretion in Mouse Proximal Tubule Perfused In Vitro. J. Am. Soc. Nephrol. 2001; 12: 177–181
  • Tidgren B. Effect of the Contrast Medium Meglumine Amidotrizoate on Renal Extraction of para-Amino Hippurate after Injection into the Renal Vein. Clin. Physiol. 1985; 5: 301–310
  • Morse G.D., Shelton M.J., Ho M., Bartos L., DeRemer M., Ragni M. Pharmacokinetics of Zidovudine and Didanosine During Combination Therapy. Antiviral Res. 1995; 27: 419–424
  • Jacob S.S., Franklin M.E., Dickinson R.G., Hooper W.D. The Effect of Diflunisal on the Elimination of Triamterene in Human Volunteers. Drug Metab. Drug Interact. 2000; 16: 159–171
  • Barry M., Howe J., Back D., Breckenridge A., Brettle R., Mitchell R., Beeching N.J., Nye F.J. The Effects of Indomethacin and Naproxen on Zidovudine Pharmacokinetics. Br. J. Clin. Pharmacol. 1993; 36: 82–85
  • Odlind B., Beermann B., Selen G., Persson A.E.G. Renal Tubular Secretion of Piretanide and Its Effects on Electrolyte Reabsorption and Tubuloglomerular Feedback Mechanism. J. Pharmacol. Exp. Ther. 1983; 225: 742–746
  • Leroy A., Humbert G., Fillastre J.P. Pharmacokinetics of Azlocillin in Healthy Subjects. Scand. J. Infect. Dis. Suppl. 1981; 29: 49–54
  • Itoh T., Ishida M., Onuki Y., Tsuda Y., Shimada H., Yamada H. Stereoselective Renal Tubular Secretion of Carbenicillin. Antimicrob. Agents Chemother. 1993; 37: 2327–2332
  • Cundy K.C. Clinical Pharmacokinetics of the Antiviral Nucleotide Analogues Cidofovir and Adefovir. Clin. Pharmacokinet. 1999; 36: 127–143
  • Gisclon L.G., Boyd R.A., Williams R.L., Giacomini K.M. The Effect of Probenecid on the Renal Elimination of Cimetidine. Clin. Pharmacol. Ther. 1989; 45: 444–452
  • Jacobs C., Coleman C.N., Rich L., Hirst K., Weiner M.W. Inhibition of cis-Diamminedichloroplatinum Secretion by the Human Kidney with Probenecid. Cancer Res. 1984; 44: 3632–3635
  • Beyer K.H., Jr, Baer J.E., Jr. Enzymes, Drugs and Transport Phenomena. Protoplasma 1967; 63: 113–120
  • Jaehde U., Sörgel F., Reiter A., Sigl G., Naber K.G., Schunack W. Effect of Probenecid on the Distribution and Elimination of Ciprofloxacin in Humans. Clin. Pharmacol. Ther. 1995; 58: 532–541
  • Dickinson R.G., King A.R., McKinnon G.E., Hooper W.D., Eadie M.J., Herkes G.K. Studies on the Renal Excretion of the Acyl Glucuronide, Phenolic Glucuronide and Sulphate Conjugates of Diflunisal. Br. J. Clin. Pharmacol. 1993; 35: 609–613
  • Inotsume N., Nishimura M., Nakano M., Fujiyama S., Sato T. The Inhibitory Effect of Probenecid on Renal Excretion of Famotidine in Young, Healthy Volunteers. J. Clin. Pharmacol. 1990; 30: 50–56
  • Cimoch P.J., Lavelle J., Pollard R., Griffy K.G., Wong R., Tarnowski T.L., Casserella S., Jung D. Pharmacokinetics of Oral Ganciclovir Alone and in Combination with Zidovudine, Didanosine, and Probenecid in HIV-Infected Subjects. J. Acquir. Immune. Defic. Syndr. Hum. Retrovirol. 1998; 17: 227–234
  • Waller E.S., Sharanevych M.A., Yakatan G.J. The Effect of Probenecid on Nafcillin Disposition. J. Clin. Pharmacol. 1982; 22: 482–489
  • Kamali F. The Effect of Probenecid on Paracetamol Metabolism and Pharmacokinetics. Eur. J. Clin. Pharmacol. 1993; 45: 551–553
  • Lam Y.W., Boyd R.A., Chin S.K., Chang D., Giacomini K.M. Effect of Probenecid on the Pharmacokinetics and Pharmacodynamics of Procainamide. J. Clin. Pharmacol. 1991; 31: 429–432
  • Overbosch D., Van Gulpen C., Mattie H. Renal Clearance of Temocillin in Volunteers. Drugs 1985; 29: 128–134
  • Davies B.E., Humphrey M.J., Langley P.F., Lees L., Legg B., Wadds G.A. Pharmacokinetics of Ticarcillin in Man. Eur. J. Clin. Pharmacol. 1982; 23: 167–172
  • Hedaya M.A., Elmquist W.F., Sawchuk R.J. Probenecid Inhibits the Metabolic and Renal Clearances of Zidovudine (AZT) in Human Volunteers. Pharm. Res. 1990; 7: 411–417
  • de Miranda P., Good S.S., Yarchoan R., Thoam R.V., Blum M.R., Myers C.E., Broder S. Alteration of Zidovudine Pharmacokinetics by Probenecid in Patients with AIDS or AIDS-Related Complex. Clin. Pharmacol. Ther. 1989; 46: 494–500
  • Liegler D.G., Henderson E.S., Hahn M.A., Oliverio V.T. The Effect of Organic Acids on Renal Clearance of Methotrexate in Man. Clin. Pharmacol. Ther. 1969; 10: 849–857
  • Furst D.E., Herman R.A., Koehnke R., Ericksen N., Hash L., Riggs C.E., Porras A., Veng-Pedersen P. Effect of Aspirin and Sulindac on Methotrexate Clearance. J. Pharm. Sci. 1990; 79: 782–786
  • Somogyi A.A., Hovens C.M., Muirhead M.R., Bochner F. Renal Tubular Secretion of Amiloride and Its Inhibition by Cimetidine in Humans and in an Animal Model. Drug Metab. Dispos. 1989; 17: 190–196
  • Kirch W., Rose I., Demers H.G., Leopold G., Pabst J., Ohnhaus E.E. Pharmacokinetics of Bisoprolol During Repeated Oral Administration to Healthy Volunteers and Patients with Kidney or Liver Disease. Clin. Pharmacokinet. 1987; 13: 110–117
  • Dutt M.K., Moody P., Northfield T.C. Effect of Cimetidine on Renal Function in Man. Br. J. Clin. Pharmacol. 1981; 12: 47–50
  • Bonde J., Pedersen L.E., Nygaard E., Ramsing T., Angelo H.R., Kampmann J.P. Stereoselective Pharmacokinetics of Disopyramide and Interaction with Cimetidine. Br. J. Clin. Pharmacol. 1991; 31: 708–710
  • Jou M.J., Huang S.C., Kiang F.M., Lai M.Y., Chao P.D. Comparison of the Effects of Cimetidine and Ranitidine on the Pharmacokinetics of Disopyramide in Man. J. Pharm. Pharmacol. 1997; 49: 1072–1075
  • Somogyi A., Stockley C., Keal J., Rolan P., Bochner F. Reduction of Metformin Renal Tubular Secretion by Cimetidine in Man. Br. J. Clin. Pharmacol. 1987; 23: 545–551
  • Bendayan R., Sullivan J.T., Shaw C., Frecker R.C., Sellers E.M. Effect of Cimetidine and Ranitidine on the Hepatic and Renal Elimination of Nicotine in Humans. Eur. J. Clin. Pharmacol. 1990; 38: 165–169
  • Somogyi A.A., Bochner F., Sallustio B.C. Stereoselective Inhibition of Pindolol Renal Clearance by Cimetidine in Humans. Clin. Pharmacol. Ther. 1992; 51: 379–387
  • Rodvold K.A., Paloucek F.P., Jung D., Gallastegui J. Interaction of Steady-State Procainamide with H2-Receptor Antagonists Cimetidine and Ranitidine. Ther. Drug Monit. 1987; 9: 378–383
  • Lai M.Y., Jiang F.M., Chung C.H., Chen H.C., Chao P.D. Dose Dependent Effect of Cimetidine on Procainamide Disposition in Man. Int. J. Clin. Pharmacol. Ther. Toxicol. 1988; 26: 118–121
  • Christian C.D., Meredith C.G., Speeg K.V. Cimetidine Inhibits Renal Procainamide Clearance. Clin. Pharmacol. Ther. 1984; 36: 221–227
  • Hardy B.G., Schentag J.J. Lack of Effect of Cimetidine on the Metabolism of Quinidine: Effect on Renal Clearance. Int. J. Clin. Pharmacol. Ther. Toxicol. 1988; 26: 388–391
  • Muirhead M.R., Somogyi A.A., Rolan P.E., Bochner F. Effect of Cimetidine on Renal and Hepatic Drug Elimination: Studies with Triamterene. Clin. Pharmacol. Ther. 1986; 40: 400–407
  • Mikus G., Eichelbaum M., Fischer C., Gumulka S., Klotz U., Kroemer H.K. Interaction of Verapamil and Cimetidine: Stereochemical Aspects of Drug Metabolism, Drug Disposition and Drug Action. J. Pharmacol. Exp. Ther. 1990; 253: 1042–1048
  • Fletcher C.V., Henry W.K., Noormohamed S.E., Rhame F.S., Balfour H.H., Jr. The Effect of Cimetidine and Ranitidine Administration with Zidovudine. Pharmacotherapy 1995; 15: 701–708
  • Yee G.C., Crom W.R., Champion J.E., Brodeur G.M., Evans W.E. Cisplatin-Induced Changes in Bleomycin Elimination. Cancer Treat. Rep. 1983; 67: 587–589
  • McCance-Katz E.F., Rainey P.M., Jatlow P., Friedland G. Methadone Effects on Zidovudine Disposition (AIDS Clinical Trials Group 262). J. Acquir. Immune. Defic. Syndr. Hum. Retrovirol. 1998; 18: 435–443
  • Somogyi A., Bochner F. Dose and Concentration Dependent Effect of Ranitidine on Procainamide Disposition and Renal Clearance in Man. Br. J. Clin. Pharmacol. 1984; 18: 175–181
  • Muirhead M., Bochner F., Somogyi A. Pharmacokinetic Drug Interactions Between Triamterene and Ranitidine in Humans: Alterations in Renal and Hepatic Clearances and Gastrointestinal Absorption. J. Pharmacol. Exp. Ther. 1988; 244: 734–739
  • Myre S.A., McCann J., First M.R., Cluxton R.J. Effect of Trimethoprim on Serum Creatinine in Healthy and Chronic Renal Failure Volunteers. Ther. Drug Monit. 1987; 9: 161–165
  • Naderer O., Nafziger A.N., Bertino J.S. Effects of Moderate-Dose versus High-Dose Trimethoprim on Serum Creatinine and Creatinine Clearance and adverse reactions. Antimicrob. Agents Chemother. 1997; 41: 2466–2470
  • Petersen P., Kastrup J., Bartram R., Molholm H.J. Digoxin-Trimethoprim Interaction. Acta Med. Scand. 1985; 217: 423–427
  • Ujhelyi M.R., Bottorff M.B., Schur M., Roll K., Zhang H., Stewart J., Markel M.L. Aging Effects on the Organic Base Transporter and Stereoselective Renal Clearance. Clin. Pharmacol. Ther. 1997; 62: 117–128
  • Kosoglou T., Rocci M.L.J., Vlasses P.H. Trimethoprim Alters the Disposition of Procainamide and N-Acetylprocainamide. Clin. Pharmacol. Ther. 1988; 44: 467–477
  • Vlasses P.H., Kosoglou T., Chase S.L., Greenspon A.J., Lottes S., Andress E., Ferguson R.K., Rocci M.L. Trimethoprim Inhibition of the Renal Clearance of Procainamide and N-Acetylprocainamide. Arch. Intern. Med. 1989; 149: 1350–1353
  • Chatton J.Y., Munafo A., Chave J.P., Steinhauslin F., Roch-Ramel F., Glauser M.P., Biollaz J. Trimethoprim, Alone or in Combination with Sulphamethoxazole, Decreases the Renal Excretion of Zidovudine and Its Glucuronide. Br. J. Clin. Pharmacol. 1992; 34: 551–554
  • Fleishaker J.C., Sisson T.A., Carel B.J., Azie N.E. Pharmacokinetic Interaction Between Verapamil and Almotriptan in Healthy Volunteers. Clin. Pharmacol. Ther. 2000; 67: 498–503

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.